This internationally renowned author team provides a unique and
thorough analysis and distillation of the endocannabinoid system
and its relationship to abdominal obesity, diabetes, and
cardiovascular disease. The endocannabinoid system (ECS) plays an
important role in cardiometabolic risk, as well as modulating
energy balance, feeding behavior, hepatic lipogenesis, and perhaps
glucose homeostasis. Evidence suggests that the ECS is overactive
in human obesity and dyslipidemia.
Critical to the management of cardiometabolic risk, this new,
timely book provides practical overviews and management guidance on
many important topics, including:
- abdominal obesity and the metabolic syndrome
- the endocannabinoid system and energy balance: functions and
dysfunctions
- abdominal obesity, the EC system, and cardiometabolic risk
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!